It's the first treatment specifically approved for thyroid eye disease. The drug was approved Tuesday by the U.S. Food and Drug Administration. It will be marketed under the brand name Tepezza.
https://ift.tt/3aFeqPs
from WebMD Health https://ift.tt/2NQjW87
by
Comments
Post a Comment